Frankfurt - Delayed Quote EUR
Vistin Pharma ASA (VP4.F)
2.1000
+0.1150
+(5.79%)
At close: April 25 at 10:37:41 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
429,503
429,503
438,328
287,675
275,812
Cost of Revenue
149,969
149,969
176,644
199,876
143,935
Gross Profit
279,534
279,534
261,684
87,799
131,877
Operating Expense
194,238
194,238
193,087
93,895
98,627
Operating Income
85,296
85,296
68,597
-6,096
33,250
Net Non Operating Interest Income Expense
-4,842
-4,842
-10,079
-2,424
-127
Pretax Income
80,453
80,453
58,518
-6,008
31,995
Tax Provision
17,770
17,770
12,923
-1,293
7,129
Net Income Common Stockholders
62,753
62,753
45,596
-4,716
24,867
Diluted NI Available to Com Stockholders
62,753
62,753
45,596
-4,716
24,867
Basic EPS
1.42
--
1.03
-0.11
0.56
Diluted EPS
1.42
--
1.03
-0.11
0.56
Basic Average Shares
44,345
--
44,345
44,345
44,345
Diluted Average Shares
44,345
--
44,345
44,345
44,345
Total Operating Income as Reported
85,296
85,296
68,597
-6,095
33,250
Total Expenses
344,207
344,207
369,731
293,771
242,562
Net Income from Continuing & Discontinued Operation
62,753
62,753
45,596
-4,716
24,867
Normalized Income
62,753
62,753
45,596
-4,716
24,867
Interest Income
9,410
9,410
20,841
28
265
Interest Expense
14,252
14,252
30,920
2,140
357
Net Interest Income
-4,842
-4,842
-10,079
-2,424
-127
EBIT
94,705
94,705
89,438
-3,868
32,352
EBITDA
113,734
113,734
106,785
8,412
42,961
Reconciled Cost of Revenue
149,969
149,969
176,644
199,876
143,935
Reconciled Depreciation
19,029
19,029
17,347
12,280
10,609
Net Income from Continuing Operation Net Minority Interest
62,753
62,753
45,596
-4,716
24,867
Total Unusual Items Excluding Goodwill
-109,329
--
--
--
--
Total Unusual Items
-109,329
--
--
--
--
Normalized EBITDA
113,734
113,734
106,785
8,412
42,961
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0002
12/31/2021 - 10/23/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade